E-139 Impact of balloon guide catheter catheterization on mechanical thrombectomy in acute stroke patients

Author(s):  
D Jeong ◽  
D Kim
Author(s):  
Juha-Pekka Pienimäki ◽  
Jyrki Ollikainen ◽  
Niko Sillanpää ◽  
Sara Protto

Abstract Purpose Mechanical thrombectomy (MT) is the first-line treatment in acute stroke patients presenting with large vessel occlusion (LVO). The efficacy of intravenous thrombolysis (IVT) prior to MT is being contested. The objective of this study was to evaluate the efficacy of MT without IVT in patients with no contraindications to IVT presenting directly to a tertiary stroke center with acute anterior circulation LVO. Materials and Methods We collected the data of 106 acute stroke patients who underwent MT in a single high-volume stroke center. Patients with anterior circulation LVO eligible for IVT and directly admitted to our institution who subsequently underwent MT were included. We recorded baseline clinical, laboratory, procedural, and imaging variables and technical, imaging, and clinical outcomes. The effect of intravenous thrombolysis on 3-month clinical outcome (mRS) was analyzed with univariate tests and binary and ordinal logistic regression analysis. Results Fifty-eight out of the 106 patients received IVT + MT. These patients had 2.6-fold higher odds of poorer clinical outcome in mRS shift analysis (p = 0.01) compared to MT-only patients who had excellent 3-month clinical outcome (mRS 0–1) three times more often (p = 0.009). There were no significant differences between the groups in process times, mTICI, or number of hemorrhagic complications. A trend of less distal embolization and higher number of device passes was observed among the MT-only patients. Conclusions MT without prior IVT was associated with an improved overall three-month clinical outcome in acute anterior circulation LVO patients.


2017 ◽  
Vol 12 (6) ◽  
pp. 659-666 ◽  
Author(s):  
Susanne Siemonsen ◽  
Nils D Forkert ◽  
Martina Bernhardt ◽  
Götz Thomalla ◽  
Martin Bendszus ◽  
...  

Aim and hypothesis Using a new study design, we investigate whether next-generation mechanical thrombectomy devices improve clinical outcomes in ischemic stroke patients. We hypothesize that this new methodology is superior to intravenous tissue plasminogen activator therapy alone. Methods and design ERic Acute StrokE Recanalization is an investigator-initiated prospective single-arm, multicenter, controlled, open label study to compare the safety and effectiveness of a new recanalization device and distal access catheter in acute ischemic stroke patients with symptoms attributable to acute ischemic stroke and vessel occlusion of the internal cerebral artery or middle cerebral artery. Study outcome The primary effectiveness endpoint is the volume of saved tissue. Volume of saved tissue is defined as difference of the actual infarct volume and the brain volume that is predicted to develop infarction by using an optimized high-level machine learning model that is trained on data from a historical cohort treated with IV tissue plasminogen activator. Sample size estimates Based on own preliminary data, 45 patients fulfilling all inclusion criteria need to complete the study to show an efficacy >38% with a power of 80% and a one-sided alpha error risk of 0.05 (based on a one sample t-test). Discussion ERic Acute StrokE Recanalization is the first prospective study in interventional stroke therapy to use predictive analytics as primary and secondary endpoint. Such trial design cannot replace randomized controlled trials with clinical endpoints. However, ERic Acute StrokE Recanalization could serve as an exemplary trial design for evaluating nonpivotal neurovascular interventions.


2019 ◽  
Vol 22 ◽  
pp. S751
Author(s):  
A. Boltyenkov ◽  
J.J. Wang ◽  
M.G. Martinez ◽  
K. Adinarayan ◽  
A.M. Hoang ◽  
...  

2016 ◽  
Vol 11 (9) ◽  
pp. 1036-1044 ◽  
Author(s):  
Seong Hwan Ahn ◽  
Ran Hong ◽  
In Sung Choo ◽  
Ji Hoe Heo ◽  
Hyo Suk Nam ◽  
...  

Background The histologic features of thrombus may differ according to the stroke subtypes. However, in acute reperfusion therapy, fibrin-specific thrombolytics are used based on the assumption that all thrombi are alike. Aims The histologic characteristics of thrombi were compared between patients with different stroke etiologies. Methods Between April 2010 and March 2012, we analyzed thrombi retrieved from acute stroke patients during mechanical thrombectomy. All thrombi were analyzed using component-specific stains such as Martius scarlet blue for fibrins and immunostaining with CD42b antibody for platelets. The stroke subtypes were determined based on the Trial of ORG 10172 in Acute Stroke Treatment classification. Results Among 36 patients, 22 were diagnosed with cardioembolism, 8 with atherothrombosis, and 6 with undetermined etiology. In arteriogenic thrombi, red blood cells were most abundant (56.9 ± 12.2%), and the platelets covered the fibrin layers or were localized at the edge or periphery of the thrombus. In cardiogenic thrombi, fibrin was most abundant (39.5 ± 13.5%), and platelets were clustered within the rich fibrin. Red blood cells proportion was greater in arteriogenic thrombi than in cardiogenic thrombi ( p < 0.001), whereas fibrin proportion was greater in cardiogenic thrombi than in arteriogenic thrombi ( p = 0.003). Of six patients with undetermined etiology, the thrombi in five showed histologic features and composition similar to that of cardiogenic thrombi. Conclusions Acute thrombi showed different histologic features according to the stroke etiology. The distribution of platelets and proportion of red blood cells and fibrin were major distinguishing factors between stroke subtypes.


Stroke ◽  
2013 ◽  
Vol 44 (suppl_1) ◽  
Author(s):  
May Nour ◽  
Fabien Scalzo ◽  
Jeffery R Alger ◽  
Sidney Starkman ◽  
Latisha K Ali ◽  
...  

Background: Reperfusion is characterized by initial restriction of blood supply followed by subsequent vascular restoration and concomitant reoxygenation of downstream tissue. In spite of mitigating initial tissue hypoxia, exacerbation of tissue injury may occur. Animal models have delineated reperfusion injury on the cellular and molecular levels, yet, no study has quantified voxel-based analyses of tissue fate due to reperfusion injury in human stroke. Methods: Evaluation included 58 stroke patients with an age range of 65±18 years, 65% of whom were woman and 35% men. All patients presented with M1 MCA occlusion and a subset received mechanical thrombectomy (38) while another received intravenous tPA followed by mechanical thrombectomy (20). Serial perfusion MRI images were obtained on presentation as well as 3-6 hours following reperfusion and processed to extract Tmax parameters. These images were co-registered serially at the voxel level with tissue fate outcomes on FLAIR and GRE 4-5 days following presentation. Reperfusion was defined by serial changes observed in Tmax voxels. The volume of reperfusion, injury, as well as tissue fate relative to initial perfusion were calculated. Results: Hemorrhage was noted on GRE in 28.9% of the patients who received thrombectomy alone and in 20% of those who received IV tPA followed by thrombectomy. In pure thrombectomy cases without later hemorrhage, average voxel-based reperfusion was 72.3% with 18% demonstrating reperfusion injury and tissue death as assessed by FLAIR imaging 4-5 days following presentation, averaging 86.2%. In patients who received IV tPA followed by mechanical thrombectomy without any subsequent hemorrhage, average voxel-based reperfusion was 66.0% with 6.2% demonstrating reperfusion injury in reperfused voxels and tissue death as assessed by FLAIR imaging 4-5 following presentation, averaging 90.3%. Conclusions: Non-hemorrhagic forms of reperfusion injury are common in acute stroke patients treated with standard therapies. Despite reperfusion and irrespective of treatment modality, substantial amounts of tissue are destined to infarct. Voxel-based analyses of serial imaging studies may provide a framework to develop therapies for reperfusion injury.


2018 ◽  
Vol 11 (2) ◽  
pp. 137-140 ◽  
Author(s):  
Yongtao Guo ◽  
Wenjie Zi ◽  
Yue Wan ◽  
Shuai Zhang ◽  
Bo Sun ◽  
...  

Background and purposeThe aim of the study was to evaluate whether leukoaraiosis severity is associated with outcome in acute stroke patients undergoing mechanical thrombectomy with stent-retriever devices.MethodsIn this retrospective multicenter study, we evaluated 251 acute stroke patients (pretreatment National Institutes of Health Stroke Scale score ≥8) treated with stent-retriever devices. Leukoaraiosis severity was graded as 0–2 (absent-to-moderate) versus 3–4 (severe) according to the van Swieten scale. The main clinical outcome was the proportion of good functional outcome, defined as a modified Rankin Scale of 0–2 at 90 days.ResultsSignificantly fewer patients in the severe LA group than in the absent-to-moderate LA group achieved a good functional outcome (18.4% vs 50.2%, P<0.001). In multivariable analysis, severe leukoaraiosis was a significant negative predictor of good functional outcome at 90 days (OR, 0.27; 95% CI 0.10–0.77; P=0.014).ConclusionsThe severity of leukoaraiosis is independently associated with 90-day functional outcome in acute stroke patients undergoing mechanical thrombectomy with stent-retriever devices.


2017 ◽  
Vol 40 (12) ◽  
pp. 1851-1860 ◽  
Author(s):  
Francisco Hernández-Fernández ◽  
Laura Rojas-Bartolomé ◽  
Jorge García-García ◽  
Óscar Ayo-Martín ◽  
Juan David Molina-Nuevo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document